A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and reduced use of crucial...
Vous n'êtes pas connecté
Multiple sclerosis (MS) is a disease where the immune system attacks the central nervous system, damaging the protective covering of nerves. It mainly affects young adults, especially women. MS can cause both physical and mental problems, like fatigue and reduced self-confidence. The disease often leads to disability and impacts daily life. However, there is limited [...] Read Full Article At: Impact of acute symptoms on multiple sclerosis recovery
A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and reduced use of crucial...
WEDNESDAY, Sept. 25, 2024 -- Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness...
Discover how identifying biomarkers can help to predict disability progression in multiple sclerosis (MS).
Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of people worldwide.
New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...
A groundbreaking study has identified key biomarkers that predict disability progression in multiple sclerosis (MS). This discovery could...
THURSDAY, Sept. 26, 2024 -- For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does...
A groundbreaking study has unveiled a critical issue of therapeutic inertia in treating women with medlinkmultiple sclerosis/medlink (MS),...
Key biomarkers identified can now predict disability progression in multiple sclerosis, offering potential for more personalized and effective...
FRIDAY, Sept. 27, 2024 -- Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression,...